Storen Legacy Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Storen Legacy Partners's ABBV Position: Q3 2026 in Review
Storen Legacy Partners reduced its AbbVie (ABBV) stake by 5.1% in Q3 2026, selling an estimated $14.6K and leaving 1,062 shares worth $278K. The position accounts for 0.07% of the portfolio, ranked #97.
Storen Legacy Partners first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $282K in Q2 2026. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Storen Legacy Partners held 1,062 shares of AbbVie worth $278K as of Q3 2026.
- Storen Legacy Partners sold 57 AbbVie shares in Q3 2026, an estimated $14.6K.
- AbbVie made up 0.07% of Storen Legacy Partners's portfolio in Q3 2026, its #97 holding.
- Storen Legacy Partners first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- Storen Legacy Partners's AbbVie position peaked at $282K in Q2 2026.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Storen Legacy Partners's 13F filing for Q3 2026, filed 9 Nov 2026.